DUBLIN, Mar. 21, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/z7tp9t/research_report) has announced the addition of the "Concise Analysis of the Chinese Osteoporosis Drug Market" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Osteoporosis is a systemic bone disease, a common disease among middle and old-aged people. It is characterized by low bone mineral density and deterioration of bone microarchitecture, which can lead to increased risks of fragility fracture. There are over 200 million osteoporosis patients around the world in the current stage. Regarding the genders of osteoporosis patients, the number of female patients is much larger than that of male patients, and the former are attacked by osteoporosis much earlier than the latter.

According to the data of Ministry of Civil Affairs of China, by the end of 2012, the population that were 60 years old and above was 193.9 million, taking up 14.3% of the total population; the population that were 65 years old and above was 127.14 million, taking up 9.4%. China has the largest old-aged population around the world, and the incidence rate of osteoporosis keeps increasing year after year. The number of patients diagnosed with osteoporosis in China is over 70 million, and the number of female patients is triple as much as that of male patients. 40%-50% patients are 60 years old or above, and about 25% patients have suffered fractures because of osteoporosis. The incidence of fracture, pain and deformation of spinal column keeps increasing.

More than 30 kinds of osteoporosis drugs have been launched into the market in the world. Clinically, bisphosphonates, parathyroid hormones, selective estrogen receptor modulators and activated vitamin D and analogues are used most often, which is the same as the situation in China. 

Key Topics Covered:

1 Basic Concepts of Osteoporosis

2 Major Therapeutic Drugs of Osteoporosis

3 Osteoporosis Drug Market, 2008-2012

4 Analysis on Hospital Market of Osteoporosis Drugs in China, 2008-2012

5 Analysis on Major Competitive Varieties in China Osteoporosis Drug Market

6 Research and Development Status of Osteoporosis Drugs

7 Perspective of China Osteoporosis Drug Market, 2013-2017


For more information visit http://www.researchandmarkets.com/research/z7tp9t/research_report

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

 

SOURCE Research and Markets